Scar Treatment Market is anticipated Market to grow at a CAGR of 10.17% from 2022 to 2028 globally - Axiom MRC
Scar Treatment Market is anticipated Market to grow at a CAGR of 10.17% from 2022 to 2028 globally - Axiom MRC
Date: March 2022
New York, December 2021: Axiom Market Research & Consulting™ added a report on scar treatment market which includes study on product, scar type, end user, and geography. Scar treatment market was projected to grow at a CAGR of 10.17% for the forecast period 2022 to 2028. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the scar treatment market.
The factors such as increasing number if the road accidents and burn cases, along with increase in the favourable reimbursement policies, increasing prevalence of the skin diseases have been accelerating the demand for the scar treatment market markets, increasing road accidents, obesity, prevalence of skin diseases, burn injuries, scarring patient, after pregnancy scars, increasing patient concerns has been driving the growth of the scar treatment market during the forecast period.
The report analyses the scar treatment market based on the product, scar type, end user and geography. Based on the product, the scar treatment market is segmented into topical products, laser products and injectables. By scar type, the scar treatment market is segmented into atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. By end user, the scar treatment is segmented into hospitals, dermatology clinics, and retail pharmacies/e-commerce. Geographically, the scar treatment market is studied for the regions including North America, Europe, Asia Pacific, and Rest of the World.
Topical product segment has gained high market share in scar treatment market
The factors such as increasing demand for the topical products, along with the increasing availability of the product in various end users and increasing patient preference for the scar type treatment has been contributing to the growth of the segment in the scar treatment market during the forecast period.
Atrophic scar type segment is likely to dominate the scar treatment market
The atrophic acne scar occur most frequently among the 80 to 90 percent of the population of the patient, and the scar treatment in the atrophic scar has specifically find the demand for the OCT topical products and also laser products with the advances in the technology has been driving the growth of the segment in the scar treatment market during the forecast period.
Hospitals end user segment to have increasing demand in the scar treatment market
The factors such as increasing patient inflow in the hospital for the treatment of the scar, along with hospitals also have well established infrastructure with the different technologically advanced products like the laser products and availability of the different topical products have been some of the main pointer which has been boosting the growth of the segment in the scar treatment market during the forecast period.
North America is expected to lead the scar treatment market
The factors such as increasing patient awareness and adoption of the scar treatment, along with the presence of the well-established manufacturer operating in the production of the scar treatment has accelerated the sales and growth of the market has been contributing to the growth of the scar treatment market in the region during the forecast period.
Key Players
The key players in the scar treatment market are Smith & Nephew (UK), Merz Pharmaceuticals (Germany), Lumenis (Israel), Sonoma Pharmaceuticals (United States), Molnlycke Health Care (Sweden), Cynosure (United States), CCA Industries (United States), Newmedical Technology (United States), Suneva Medical Inc. (United States), Perrigo Company Plc (Ireland), Bausch Health Companies (Canada), Sientra Inc. (United States), Pacific World Corporation (United States), Rejuvaskin (United States) and HRA Pharma (France) among others.